Delivery Order SPE2DB25D3404-SPE2DB25FUQEE
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $71K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a Delivery Order contract by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of RINVOQ ER 15 MG tablets in quantities of 30 units. This firm fixed price delivery order, valued at $11,576.19, represents a non-competitive award under DLA's pharmaceutical supply chain supporting federal medical procurement needs. The contract is scheduled for completion by August 6, 2025, with performance originating from AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $3,700.62 delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose packages). The contract represents a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 18, 2025. This award was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 14, 2025, by the Defense Logistics Agency to supply RINVOQ ER 15 mg tablets in quantities of 30 units. The contract carries a firm fixed price ceiling value of $31,161.95 and is scheduled for completion by August 15, 2025. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded delivery order representing a standard transaction within the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 29, 2025, by the Defense Logistics Agency (DLA) for the supply of RINVOQ ER 45 MG tablets (28-count units). The contract, valued at $60,445.18, is structured as a firm fixed price delivery order with an ultimate completion date of September 2, 2025. This award represents a non-set-aside, competitively awarded procurement and is issued as a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $37,122.24 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $274,266.46 by the Defense Logistics Agency's Medical Supply Chain to supply RINVOQ ER 45 mg tablets in a quantity of 28 units. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizing firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 30, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose) valued at $11,415.23. This firm fixed-price contract award was competitively procured with no set-aside designation and carries an ultimate completion date of July 31, 2025. The delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, which procures...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.70 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $26,755.07 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on June 18, 2025, with completion expected by June 20, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $28,730.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship...